Related Experiment Videos
New evidence of circulating immune complexes in Crohn's disease using two sensitive methods
Journal of Clinical & Laboratory Immunology
|January 1, 1981
Summary
Circulating immune complexes (AgAb) are more prevalent in Crohn's Disease patients. These immune complexes may be a secondary phenomenon, with varying presence based on disease activity.
Area of Science:
- Immunology
- Gastroenterology
Background:
- Crohn's Disease (CD) is a chronic inflammatory bowel disease.
- The role of circulating immune complexes (AgAb) in CD pathogenesis is not fully understood.
Purpose of the Study:
- To investigate the prevalence and characteristics of circulating immune complexes (AgAb) in patients with Crohn's Disease.
- To explore the potential association of AgAb with disease activity and complications in CD.
Main Methods:
- Solid phase C1q binding test and conglutinin binding assay were used to detect AgAb in 183 serum samples from 119 CD patients.
- Comparison of AgAb prevalence in CD patients versus a control population.
- Correlation analysis between AgAb detection and clinical parameters like disease activity and complications.
Main Results:
- A significantly higher prevalence of circulating AgAb was found in CD patients compared to controls.
- Combined testing detected AgAb in approximately half of the sera; individual methods identified AgAb in about one-third.
- AgAb detected by C1q-SP correlated with disease activity and complications, unlike those detected by conglutinin assay.
Conclusions:
- Circulating immune complexes are present in Crohn's Disease patients.
- The detected AgAb material appears heterogeneous, suggesting different types or origins.
- Circulating immune complexes in CD might represent a secondary phenomenon rather than a primary cause.